MEDINOL IN NEW PATENT CLAIM VS BOSTON SCIENTIFIC

Israel's Medinol has lodged a new legal claim against Boston Scientific Corp, asserting several of its patents were violated by the latter's next-generation coronary stents, the Wall Street Journal reported on Wednesday.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=governmentFilingsNews&storyID=URI:urn:newsml:reuters.com:20060222:MTFH85476_2006-02-22_08-54-49_N22240295:1)